GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 111 filers reported holding GENOMIC HEALTH INC in Q2 2014. The put-call ratio across all filers is 5.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,206,000 | +156.9% | 474,874 | +120.3% | 0.03% | +25.9% |
| Q2 2019 | $12,538,000 | +9.5% | 215,537 | +31.8% | 0.03% | +8.0% |
| Q1 2019 | $11,453,000 | +60.5% | 163,500 | +47.6% | 0.02% | +38.9% |
| Q4 2018 | $7,137,000 | +32.0% | 110,800 | +43.9% | 0.02% | +63.6% |
| Q3 2018 | $5,407,000 | +23.9% | 77,000 | -11.1% | 0.01% | +10.0% |
| Q2 2018 | $4,365,000 | +34.9% | 86,600 | -16.2% | 0.01% | +25.0% |
| Q1 2018 | $3,235,000 | +5.6% | 103,400 | +15.4% | 0.01% | 0.0% |
| Q4 2017 | $3,064,000 | +20.3% | 89,600 | +12.4% | 0.01% | -27.3% |
| Q4 2014 | $2,548,000 | +9.0% | 79,700 | -3.5% | 0.01% | 0.0% |
| Q3 2014 | $2,338,000 | -34.4% | 82,600 | -36.5% | 0.01% | -35.3% |
| Q2 2014 | $3,562,000 | +42.8% | 130,000 | +37.3% | 0.02% | +41.7% |
| Q1 2014 | $2,494,000 | -6.7% | 94,700 | +3.7% | 0.01% | -14.3% |
| Q4 2013 | $2,672,000 | -33.4% | 91,300 | -30.5% | 0.01% | -36.4% |
| Q3 2013 | $4,015,000 | -32.9% | 131,300 | -30.4% | 0.02% | -35.3% |
| Q2 2013 | $5,981,000 | – | 188,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |